Compare Adaptive Biotechnologies Corp (ADPT) vs AES Corp (AES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs AES Corp — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while AES Corp trades at $14.7 (market cap $10.49B). The key difference: AES Corp is far larger — about 2.6× Adaptive Biotechnologies Corp's market cap, and AES Corp pays a 4.79% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | AES | |
|---|---|---|
Market Cap | $4.04B | $10.49B |
Sector | Health | Utilities |
52-Week High | $25.45 | $17.28 |
52-Week Low | $12.30 | $12.51 |
Enterprise Value | $4.10B | $40.75B |
Dividend Yield | — | 4.79% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About AES Corp
AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →
